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Drug-Coated Devices for Peripheral Arterial Disease
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and should collect long-term mortality data. Similarly, the FDA
now routinely reviews longer-term
data for PCDs for which market
authorization is being sought
when they are intended to treat
patients with PAD, and the agency
requests that trials capture information on adjunctive antithrombotic therapy and medications
indicated for patients with atherosclerosis.
We are fortunate to live in an
era when numerous beneficial
treatment options are available
for patients with PAD. These patients should receive the best available medical therapy and guidance to promote healthy lifestyles,
including weight control, smoking cessation, and exercise. For
patients requiring further treatment to relieve symptoms, we
know that PCDs improve blood
flow to the legs and are more
likely than uncoated devices to
avert the need for repeat procedures to reopen blocked blood
vessels. The benefits and risks
associated with available PAD

treatment options should be carefully considered and discussed
with individual patients. The use
of a PCD may be the best treatment for some patients, particularly those judged to be at particularly high risk for restenosis
and repeat femoropopliteal interventions. Additional data are needed to further refine optimal treatment strategies for patients on
the basis of their risk profile for
restenosis, incorporating patientspecific factors (e.g., presence of
diabetes, endothelial dysfunction,
increased platelet activity, or systemic inflammation) and lesionspecific factors (e.g., small-diameter vessels, long lesions, high
plaque burden, or reduced distal
runoff).
The FDA will continue to work
with investigators, medical professional societies, and the device industry to facilitate data
development and to communicate with the public as new information becomes available.
Disclosure forms provided by the authors
are available at NEJM.org.

From the Center for Devices and Radiological Health, Food and Drug Administration,
Silver Spring, MD.
This article was published on January 9,
2021, at NEJM.org.
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O

ne slow afternoon in urgent
care, the triage nurse came
and found me in the doctors’
room to tell me a patient had arrived. He handed me a vitals sheet,
wrote the patient’s initials on the
white board with “pneumonia”
as the working diagnosis, and
then described the situation. The
nurse wore an expression of dispassionate exasperation that I have
seen only on experienced clinicians. With a subtle eye roll, he
asked, “Do you know this patient?

She’s been here a bunch of times.
She’s also mad as hell.”
I didn’t know her, and as the
nurse talked, I formed a differential in my head. The patient had
been living with HIV for a decade
and she’d had a CD4 count of
about 200 cells per cubic millimeter 6 months ago and was not
consistently on treatment (so opportunistic infections were possibilities). Two weeks earlier, she’d
been admitted with a diagnosis
of bacterial pneumonia and dis-
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charged after treatment (could it
be recrudescence, or was the initial diagnosis incomplete?). She
was not taking pneumocystis prophylaxis (so nosocomial or opportunistic infection?).
Her case was coming into focus: AIDS-range immunosuppression, not on antiretroviral treatment, unresolved pneumonia. I
was already mentally making my
case for admission. When the
nurse got to the physical exam,
however, the vitals were reassur-
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ing: “The heart rate is 80, BP is
120/80, the respiratory rate is 20,
her temp is 98.0, she’s satting
100%.” With my enthusiasm for
admission now in question, I
went to see the patient.
I hadn’t asked what she was
mad about, but I was interested
to see. She was sitting in the chair
in the exam room, knotted up,
squirming and restless — the
picture of agitation. Before I could
introduce myself, she cursed that
no one was helping her. I tried
my usual lines — “I’m sorry
things have been frustrating.”
and “I’m here to help.” and “We
can figure this out together.” —
as I tried to elicit some history
of her respiratory symptoms. She
flatly refused to answer, instead
insisting that I call her case worker about housing. After a few more
attempts to assess the pneumonia, I grew a little impatient.
Housing problems, though important, are generally intractable
— patients stay on waiting lists
for years. Urgent care was not the
place to address housing.

102

But I had no other patients
waiting, so I said I’d check to see
if a social worker was available,
suspecting that most likely none
would be. In the hall, the triage
nurse, who’d heard the yelling,
asked, “Everything OK in there?”
I forced a grin as I passed. Having worked in a safety-net hospital for most of my life, I take
some pride in getting into difficult situations, solving the problem, and coming out unscathed,
but I was having some doubts.
As expected, no social workers
were available.
I returned to the room, hoping
my attempt would create enough
goodwill to permit discussion of
the pneumonia. But the patient
resumed her vociferous demands
that I call her case worker. “Wow,”
I thought, “I’m really not getting
anywhere this time.” I plotted a
second exit. But first I thought I
would make one additional gesture — I picked up the phone
and dialed the number she wanted me to call. To my surprise, a
woman answered.

n engl j med 384;2
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“Yes, are you the doctor?” she
said. “So glad you called. I asked
Ms. X to have a doctor call.”
I was intrigued — staff at
overstretched community organizations rarely answer phones immediately. The case worker explained that the patient had been
living in a shelter and had waited
for years on a list for housing,
but the list was slated to be
closed, with the remaining clients
unable to be placed. The case
worker had been calling the clinic but hadn’t gotten through. The
patient had been despondent and
agitated since hearing about the
list. A doctor’s note of medical
necessity might bump her up before the list closed for good.
Given the strong association
between stable housing and viral
suppression,1 I said I was happy
to write a note. I drafted it on
the computer in the exam room,
sent it to the case worker, and
handed the patient a hard copy.
The letter calmed the patient considerably. She moved to the exam
table, and we had a conversation.
She answered my questions about
her pneumonia, and I was satisfied that it was resolving.
In 1960, political scientist
Michael Lipsky coined the term
“street-level bureaucrats” to describe people on the front lines
of governmental services and systems — police, teachers, social
workers, and others — who exercise a tremendous amount of discretion in their decisions, including biases, whether implicit or
explicit. A police officer who pulls
you over for rolling through a
stop sign can issue you a verbal
warning or a substantial fine. A
teacher can punish misbehaving
students or give them some latitude. Although not usually con-
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ceptualized in this way, doctors
are, now more than ever, streetlevel bureaucrats. When a patient
is 15 minutes late for an appointment, we decide whether to
squeeze them in or reschedule.
We can empathize with a patient
over a long wait or admonish
them for being testy. Surgeons
can refuse cases when the patient has used illicit drugs that
might increase the risk posed by
a procedure, even if that procedure could be lifesaving. These
decisions have particularly significant effects on people whose
circumstances render them most
vulnerable — those who have no
housing, have mental health diagnoses, are targets of structural
racism, or have chronically poor
access to care.
Often in making these decisions, when we’re faced with a
choice between defending the system and advocating for the patient, we instinctively choose the
former. We are not “supposed”
to deal with housing in urgent
care, and diagnosing and managing acute medical problems
would be impossible if we did so
routinely. But there is no rule saying that on a day when no other
patients are waiting we can’t address housing issues in urgent
care, just as we would if we saw
the same in primary care a day
or two later. In a system in which
the greatest challenges are often
not clinical interventions but fragmentation, access, and quality of
care, doctors are uniquely able to

bend the rules to make things
work for our patients.
As the encounter came to an
end, we talked a bit. She explained how distressing it was to
be homeless, especially as a transgender woman who faced harassment in the shelter system; she
told me about the discrimination
and vulnerability she felt and
about her longing for a home. Is
housing a doctor’s problem? Perhaps not. But if the consequences
of poor housing are no different
from those of nonadherence or
the wrong antiretroviral regimen,
we can’t afford to ignore it even
if we can’t single-handedly remedy it.
After the patient left, I wondered whether I had really helped
her to get housed, and whether
housing would improve her clinical condition. What other issues
in her life — mental illness, substance abuse, discrimination —
would continue to affect her even
if housing were found? I don’t
know, and I never saw her again.
Nevertheless, the encounter
left me with a feeling that I don’t
always have at the end of a day
of urgent care. I had given someone the help they wanted. I had
been able to do so because I was
a doctor, but the help I gave had
nothing to do with being a doctor. It had to do with being
human.
We have come to see health
care as a system, in which we’ve
found ways to standardize and
simplify, to create productive rou-
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tines. Quality-improvement skills
are now taught in medical school.
Yet despite our efforts, much of
the system is still broken. Information systems are still not well
linked. The price of insurance
can be exorbitant. Unnecessary
clinical documentation for billing
saps our morale. Referrals are a
labyrinth. Differential and discriminatory access that further
disadvantages the poor, African
Americans, and other minorities
are unjust. Why assiduously defend the system if it has betrayed
us and our patients? Though
doctors may not be able to immediately fix the system, we may
sometimes find ourselves uniquely positioned to resist its failings
— and to thereby help both ourselves and our patients. Such resistance may offer some, if incomplete, redemption for the ways
in which our systems have fallen
short of our ideals.
Identifying details have been changed to
protect the patient’s privacy.
Disclosure forms provided by the author
are available at NEJM.org.
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